deltatrials
Completed OBSERVATIONAL NCT01332734

Microcirculatory Changes During Magnesium Sulphate Infusion in Sepsis

Microcirculatory Changes During Open Label Magnesium Sulphate Infusion in Severe Sepsis and Septic Shock

Sponsor: Frisius Medisch Centrum

Interventions Magnesium Sulfate
Updated 6 times since 2017 Last updated: Apr 4, 2011 Started: Mar 31, 2010 Primary completion: Aug 31, 2010 Completion: Jan 31, 2011
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01332734, this observational or N/A phase trial focuses on Septic Shock and Severe Sepsis and remains completed. Sponsored by Frisius Medisch Centrum, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Apr 2018 · 15 months · monthly snapshotCompleted~Apr 2018 – ~Jan 2021 · 33 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Jun 2025 · 9 months · monthly snapshotCompleted~Jun 2025 – present · 13 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Jun 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Jun 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Jan 2021 — Jul 2024 [monthly]

    Completed

  5. Apr 2018 — Jan 2021 [monthly]

    Completed

    Phase: NANone

Show 1 earlier version
  1. Jan 2017 — Apr 2018 [monthly]

    Completed NA

    First recorded

Mar 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Frisius Medisch Centrum
  • Lithuanian University of Health Sciences
Data source: Frisius Medisch Centrum

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations